New Advances in Drug Repurposing for Oncology

Dear Colleagues,

The concept of drug repurposing is associated with a simple but powerful insight: some drugs originally used to treat one condition can be found to successfully treat other conditions, such as cancer. Several approaches and strategies have been developed in the past to drive new drug treatments for cancer and have introduced laboratory and regulatory requirements into the clinical setting. New pharmacological targets, immunotherapies as adjuvants, in silico simulation studies or synergistic drug combinations are examples of innovation in the field of drug repurposing.

In this Special Issue, original research studies or reviews focused on these topic areas are welcome. The main objective is to summarize the approaches used for drug repurposing in oncology and discuss the main barriers to its uptake.

Topics will include, but are not limited to:

• Drug repurposing in oncology
• De novo discovery and development
• Oncology precision medicine
• Technological approaches
• Combinatorial therapy
• Drug metabolism
• Genomic and proteomic technologies
• Computational and in silico studies
• Intermolecular interactions

We look forward to receiving your contributions. 

For all the papers submitted to this Special Issue, an Editorial Board member from Biomolecules who do not have conflict of interest will be invited to make decisions to avoid any conflict of interest.

Dr. Nuno Vale
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Biomolecules is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.